Bosire: Vaccinate girls to save them from cervical cancer

HPV vaccine

A healthcare worker administers the cervical cancer vaccine to Mwajuma Jillo at Hola Referral Hospital. 

Photo credit: File | Nation Media Group

What you need to know:

  • Cervical cancer is the leading cause of cancer death among Kenyan women aged 15 to 44 years.
  • Vaccinating efforts against HPV also improve and prolong life for adolescents and young people living with HIV.
  • The vaccine targets the HPV subtypes accountable for 70 per cent of cervical cancer.

Despite the world convening for ICPD25+ in 2019 and Global leaders making commitments to safeguard the health of women and young girls, there continues to be increased opposition against reproductive rights of women; opposition that has hindered access to safe reproductive services including cervical cancer prevention interventions. As a young girl who grew up in the slums of Kibera, in an environment where quality, affordable and timely healthcare did not exist, this reality remains true for many young girls living in poor households in Kenya.

Welcome!

You're all set to enjoy unlimited Prime content.